top of page

"Breaking Down the Science: Illustrating the updates on the Cell-free DNA-derived methylome for Coronary artery disease"

  • Writer: Xulfikar Mehdi
    Xulfikar Mehdi
  • Apr 7, 2024
  • 1 min read

Recently, our research team at the Central Molecular Lab, GIPMER published a review article entitled, "An update on the cell-free DNA-derived methylome as a non-invasive biomarker for coronary artery disease". The highlights of this article were;

  • Cardiac cell necrosis by atherosclerotic plaque rupture triggers myocardial infarction.

  • Cell-free DNA released from the necrotized cells represents the tissue specificity.

  • cfDNA is explored to comprehend the epigenomic landscape and CAD pathophysiology.

  • The differential methylation pattern in CAD patients can be a potential biomarker(s) to detect CAD.

I was very fortunate to contribute in the drafting and visualization part of this manuscript. Here are the illustrations that I made using Adobe Illustrator that got published in this article;


ree

Graphical abstract: Highlights the risk factors associated with CAD, methods to study and applications of the data derived from exploring the methylome from cfDNA of CAD patients.


ree

Figure 1: Schematic representation of the homocysteine pathway in its normal homeostasis and the epigenetic changes leading to atherosclerosis. 



ree

Figure 2: Technical approaches to study methylation with their advantages, and limitations. 



Comments


bottom of page